These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21601624)

  • 1. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers.
    Ha JU; Xanthos M
    Int J Pharm; 2011 Jul; 414(1-2):321-31. PubMed ID: 21601624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of agar as a novel filler for monolithic matrices produced using hot melt extrusion.
    Lyons JG; Devine DM; Kennedy JE; Geever LM; O'Sullivan P; Higginbotham CL
    Eur J Pharm Biopharm; 2006 Aug; 64(1):75-81. PubMed ID: 16697170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailor-made release triggering from hot-melt extruded complexes of basic polyelectrolyte and poorly water-soluble drugs.
    Kindermann C; Matthée K; Strohmeyer J; Sievert F; Breitkreutz J
    Eur J Pharm Biopharm; 2011 Oct; 79(2):372-81. PubMed ID: 21596136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a pH-responsive imprinted polymer for diclofenac and study of its binding properties in organic and aqueous media.
    Mohajeri SA; Malaekeh-Nikouei B; Sadegh H
    Drug Dev Ind Pharm; 2012 May; 38(5):616-22. PubMed ID: 21978326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery.
    Shen X; Yu D; Zhu L; Branford-White C; White K; Chatterton NP
    Int J Pharm; 2011 Apr; 408(1-2):200-7. PubMed ID: 21291969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
    Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
    Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.
    Yang M; Cui F; You B; Wang L; Yue P; Kawashima Y
    Int J Pharm; 2004 Nov; 286(1-2):99-109. PubMed ID: 15501006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of polymers on dissolution performance of an amorphous gelleable drug from surface-coated beads.
    Fan C; Pai-Thakur R; Phuapradit W; Zhang L; Tian H; Malick W; Shah N; Kislalioglu MS
    Eur J Pharm Sci; 2009 Apr; 37(1):1-10. PubMed ID: 19027852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diclofenac release from eudragit-containing matrices and effects of thermal treatment.
    Billa N; Yuen KH; Peh KK
    Drug Dev Ind Pharm; 1998 Jan; 24(1):45-50. PubMed ID: 15605596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrudable core system: development of a single-layer osmotic controlled-release tablet.
    Waterman KC; MacDonald BC; Roy MC
    J Control Release; 2009 Mar; 134(3):201-6. PubMed ID: 19100796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system.
    Efentakis M; Iliopoyloy A; Siamidi A
    Drug Dev Ind Pharm; 2011 Jan; 37(1):113-20. PubMed ID: 20615155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.